Home › Esophageal Adenocarcinoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Esophageal Adenocarcinoma sa Boston, MA

Isang pag-aaral para sa Esophageal Adenocarcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07544589

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Nagre-recruitPhase 3

Boston Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05677490

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Nagre-recruitPhase 1

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06324357

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

Nagre-recruitPhase 2

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07546812

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Nagre-recruit

Beth Israel Deaconess Medical Center, Boston

Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Nagre-recruitPhase 3

Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07431281

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1

Normunity Investigational Site, Boston
Normunity Investigational Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Brigham & Women's Hospital, Boston
Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
at 2 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Nagre-recruitObservasyonal na pag-aaral

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07675967

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07284186

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Nagre-recruitPhase 2

I-Mab Site 1002, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT07432295

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Mass General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT04900818

Pag-aaral para sa Esophageal Adenocarcinoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.